BDB-001 Phase III Trial in ANCA-Associated Vasculitis

Clinical trial NCT07168161 · RECRUITING

Trial details

NCT number: NCT07168161
Sponsor: Staidson (Beijing) Biopharmaceuticals Co., Ltd
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

ANCA Associated Vasculitis (AAV)

Start date: 2025-11-10
Primary completion: 2027-04-16
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.